help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2005-0302
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boisen, K. A.
Right arrow Articles by Main, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boisen, K. A.
Right arrow Articles by Main, K. M.
Related Collections
Right arrow Pediatric Endocrinology
Right arrow Male Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 7 4041-4046
Copyright © 2005 by The Endocrine Society

Hypospadias in a Cohort of 1072 Danish Newborn Boys: Prevalence and Relationship to Placental Weight, Anthropometrical Measurements at Birth, and Reproductive Hormone Levels at Three Months of Age

K. A. Boisen, M. Chellakooty, I. M. Schmidt, C. M. Kai, I. N. Damgaard, A.-M. Suomi, J. Toppari, N. E. Skakkebaek and K. M. Main

University Department of Growth and Reproduction Rigshospitalet (K.A.B., M.C., I.M.S., C.M.K., I.N.D., A.-M.S., J.T., N.E.S., K.M.M.), DK-2100 Copenhagen, Denmark; and Departments of Physiology and Paediatrics (A.-M.S., J.T.), University of Turku, FIN-20520 Turku, Finland

Address all correspondence and requests for reprints to: Katharina M. Main, M.D., Ph.D., University Department of Growth and Reproduction, GR-5064 Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark. E-mail: katharina.main{at}rh.hosp.dk.


    Abstract
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Context: Hypospadias is one of the most frequent male congenital malformations and may be part of the testicular dysgenesis syndrome.

Objective: The aim of the study was to investigate the prevalence of hypospadias in Denmark and evaluate the relationship to anthropometrical measurements at birth and reproductive hormone levels at 3 months of age.

Design: A prospective cohort study was conducted with 3-yr follow-up (1997–2004).

Setting: The population-based study was conducted at the University Hospital of Copenhagen.

Participants: A total of 1072 Danish boys were consecutively recruited antenatally, with 74.4% completing the study.

Main Outcome Measures: The study examined the position of the urethral meatus, anthropometrical measurements, placental weight, and reproductive hormone levels.

Results: The Danish birth prevalence of hypospadias was significantly higher than in a concomitant Finnish study (1.03 vs. 0.27%; P = 0.012). At 3 yr, the true prevalence was found to be 4.64% because additional mild cases were detected when physiological phimosis dissolved. Weight for gestational age (percentage deviation from expected mean) (–5.00 vs. –0.59%; P = 0.030) and placental weight (567 vs. 658 g; P = 0.023) were significantly lower, and FSH was significantly higher (1.48 vs. 1.15 IU/liter; P = 0.007) in boys with hypospadias, compared with healthy boys.

Conclusions: We found a surprisingly high total rate of hypospadias of 4.6% in this large prospective cohort study. Seventy-two percent of the cases were apparent only after the prepuce could be retracted. Hypospadias were associated with elevated serum FSH levels at 3 months. We also confirmed an association between fetal growth impairment and hypospadias; however, it is yet unknown whether this indicates a causal relationship or a shared pathogenic factor.


    Introduction
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
HYPOSPADIAS IS ONE of the most frequent congenital malformations in males. In register-based studies, large geographic differences have been found with prevalence rates ranging from 2 to 39 per 10,000 total live-born births (1, 2, 3, 4). Analyses of Danish population based data from the Medical Birth Register have shown an increasing trend in the rate of hypospadias from 1970 to 1981 and a birth prevalence of 11.3 per 10,000 live-born births in 1980–1981 (1). The etiology is obscure in most cases. Several register-based studies have found impaired intrauterine growth associated with hypospadias (1, 5). However, substantial over- and underascertainment of cases in registers has been documented (1, 2, 6).

During recent decades, several reports have indicated that Danish males carry a higher risk of testicular cancer and subfertility than Finnish males (7). We have previously reported also a significantly higher birth prevalence of cryptorchidism in Danish boys, compared with Finnish boys (8). The clinical and epidemiological associations among cryptorchidism, subfertility, and testicular cancer suggest the existence of etiological and pathogenic links, possibly due to a testicular dysgenesis syndrome (TDS). The clinical symptoms of TDS differ in severity and prevalence and may also include hypospadias (7).

The aim of this prospective cohort study was to describe the current birth rate of hypospadias in Denmark to assess whether it follows the same regional pattern as other features of TDS. The relationship between hypospadias and anthropometrical measurements at birth (as a marker of intrauterine growth) and reproductive hormone levels at 3 months of age was evaluated in boys with hypospadias in comparison with healthy boys.


    Subjects and Methods
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Study design

The study was conducted as a prospective cohort study at the University Hospital of Copenhagen in Denmark from 1997–2004. The recruitment, study design, and ascertainment of urogenital malformations were performed in close collaboration with a Finnish study group and have previously been described (8).

Eligible women residing in the hospital referral area were consecutively recruited during the first trimester of pregnancy. To obtain a genetically and geographically well-defined population, only families who met the following criteria were included: both parents and grandparents of the unborn child had to be born and raised in Denmark with a maximum residence abroad of 3 yr for the mother and 10 yr for the father and grandparents.

The boys were examined shortly after birth and at 3, 18, and 36 months of age. In case of preterm birth, all examinations were postponed according to the expected date of delivery. Gestational age was based on routine ultrasonography in pregnancy wk 18–20, when available. In the remaining cases (2.1%), the last menstrual period was used. Birth weight (grams), birth length (centimeters), and head circumference (centimeters) were obtained from birth records. Weight for gestational age (WGA) was expressed as percentage deviation from the expected mean WGA using a gender-specific equation (9). Small for gestational age (SGA) was defined as less than –22% WGA approximate to –2 SD. Placentas were collected by midwives and stored at –20 C. They were subsequently weighed frozen at our department on a digital scale (Baby-Scale model; Solotop Oy, Vantaa, Finland) to the nearest 0.005 kg. At all subsequent examinations of the boys, weight was measured on a digital scale (Solotop Oy, Baby-Scale model) to the nearest 0.005 kg. Length was measured with the child supine on a portable infantometer (Kiddimeter, Raven Equipment Limited, Essex, UK) to the nearest 0.01 cm. At the age of 3 yr, an electronic stadiometer was used (Force Technology, Brøndby, Denmark). Head circumference was measured with a tape lasso (Lasso, Child Growth Foundation, London, UK) to the nearest 0.01 cm. For all above variables, the mean of three measurements was calculated.

Genital malformations and retractability of the prepuce were noted at all examinations. Only one boy was circumcised due to medical reasons. The location of the urethral meatus was described if visible, and hypospadias was graded as glandular, coronal, penile, penoscrotal, scrotal, or perineal according to the anatomical position (Fig. 1Go). Cases of isolated malformed foreskin without hypospadias were not included as cases.



View larger version (11K):
[in this window]
[in a new window]
 
FIG. 1. Types of hypospadias classified by the anatomical position of the urethral meatus. 1, Glandular; 2, coronal; 3, penile; 4, penoscrotal; 5, scrotal; 6, perineal.

 
Hormone assays

Venous blood samples were obtained at the 3-month examination. Serum was stored at –20 C and later analyzed. Serum concentrations of FSH, LH, SHBG, testosterone, and inhibin B were measured. All analyses were done blinded at the laboratory at the University Department of Growth and Reproduction. Serum FSH, LH, and SHBG were measured by time-resolved immunofluorometric assays (Delfia; Wallac Inc., Turku, Finland) with detection limits of 0.06 and 0.05 U/liter for FSH and LH, respectively, and 0.23 nmol/liter for SHBG. Intra- and interassay coefficients of variation (CVs) were less than 5% in both gonadotropin assays and less than 6% in the SHBG assay. Serum testosterone was measured by RIA (Coat-a-Count; Diagnostic Products Corp., Los Angeles, CA) with a detection limit of 0.23 nmol/liter and intra- and interassay CVs less than 10%. Serum inhibin B was analyzed by a double-antibody enzyme immunometric assay using a monoclonal antibody raised against the inhibin ßB-subunit in combination with labeled antibody raised against the {alpha}-subunit (Oxford Bio-Innovation, Oxford, UK). The detection limit was 20 pg/ml, and intra- and interassay CVs were less than 15% and less than 20%, respectively.

Analyses of the androgen receptor

DNA was isolated from EDTA-stabilized blood samples. All exons and part of the flanking introns were PCR amplified using the primers described by Batch et al. (10). The PCR products were scanned for mutations by single-strand conformation analysis. Products with an aberrant single-strand conformation analysis pattern were sequenced and subsequently sequenced using the Sequenase kit (version 2.0; USB Corp., Cleveland, OH) (11).

Participants

Of 2095 live-born children, 1072 boys entered the study. A total of 1052 boys were examined at birth or the expected date of delivery; 971 of these were reexamined 3 months later. The remaining 81 families were lost to follow-up. Twenty boys were seen only at 3 months and the subsequent examinations because they either left the hospital before being examined neonatally or the examination was postponed due to medical problems. Eight hundred ninety boys were reexamined at 18 months of age and 798 boys at 3 yr of age, whereas 101 and 92 families, respectively, were lost to follow-up.

Statistical analysis

Statistical analyses were performed using SPSS for Windows 11.0 (SPSS, Inc., Chicago, IL). Prevalences are given as cases per boys examined in the study. The prevalence at 3 months of age is also given as cases per total number of live-born births, including girls. Ninety-five percent confidence intervals (CIs) on prevalence rates were calculated using R (12) and given in parentheses. {chi}2 statistics, based on 2 x 2 cross-tabulations, were used for comparison of hypospadias rates between countries. All anthropometrical measurements followed normal distribution, and differences between groups were tested with unpaired t test. Univariate general linear regression models tested linear trends in the anthropometrical measurements. Reproductive hormones did not follow normal distribution and were described by median and 95% prediction intervals. Differences were tested using the Mann-Whitney U test.

Ethics

The study was conducted according to the Helsinki II Declaration and was approved by the local Danish ethics committee [(KF) 01-030/97] and the Danish Data Protection Agency (1997-1200-074). The parents gave written informed consent.


    Results
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Prevalence of hypospadias

There were eight cases of hypospadias at birth [0.75% (95% CI 0.32–1.47%)]. The prepuce was malformed in all cases. Glandular hypospadias was diagnosed in one case; the boy suffered from additional cleft palate and congenital hypothyroidism. Coronal hypospadias was found in four cases, and three cases were distal penile. In two of the latter, additional cryptorchidism was present, in one boy combined with atresia of the tricuspid valves of the heart. The third boy with penile hypospadias suffered from atrial and ventricular septal defects. We found normal male karyotype (46,XY) and no androgen receptor mutations in these three boys. Numbers of CAG repeats were 21, 22, and 25, respectively. The normal range in Denmark is 14–33, median 21 (13). Isolated malformation of the foreskin without hypospadias was detected in four boys.

At 3 months, two additional glandular and one coronal hypospadias were detected (Table 1Go); in none of these the prepuce was split. Thus, the prevalence of hypospadias among live-born boys was 1.03% (95% CI, 0.51–1.83) or 5.25 per 1000 live-born births (95% CI, 2.62–9.38/1000).


View this table:
[in this window]
[in a new window]
 
TABLE 1. Age of diagnosis and type of hypospadias

 
Additional cases of mild hypospadias became apparent as the physiological agglutination of the otherwise normal-looking prepuce dissolved during the study period (Table 1Go). At birth, the prepuce could be retracted in 27% of boys, at 18 months of age in 53%. At 3 yr, the prepuce could be retracted in 62% of boys (in 2% status was not noted). In 4.64% (95% CI, 3.38–6.34%) of the 3-yr-old boys, displacement of the urethral meatus was present. In two of the boys with glandular hypospadias diagnosed at 3 yr, congenital cryptorchidism with spontaneous testicular descent before 3 months were present. In one case with delayed diagnosis of glandular hypospadias, testicular ascent (acquired cryptorchidism) was also present. If including only boys with retractable prepuce at 3 yr (n = 495), the prevalence of hypospadias was 7.5%.

Anthropometrical data at birth

At birth, we found signs of impaired intrauterine growth in boys with hypospadias, irrespective of type and age at diagnosis. Mean (SD) weight for gestational age was significantly smaller [–5.00% (11.3) vs. –0.59% (12.4), P = 0.030] and placental weight was lower [567 g (108) vs. 658 g (142), P = 0.023], compared with boys with no urogenital malformations. However, only one boy with (penile) hypospadias was born SGA (WGA = –42.54%), whereas the rest of the cases were born with appropriate weight for gestational age (range –21.09 to 24.18).

In boys with coronal or penile hypospadias, birth weight (P = 0.027), length (P = 0.030), head circumference (P = 0.030), and WGA (P = 0.011) were smaller than in healthy boys (Table 2Go). We found a decreasing linear trend for birth weight (P = 0.005), birth length (P = 0.015), head circumference (P = 0.002), and weight for gestational age (P = 0.008) with more severe type of hypospadias (glandular-coronal-penile) (Fig. 2Go).


View this table:
[in this window]
[in a new window]
 
TABLE 2. Anthropometrical measurements at birth and placental weight [mean (SD)] in boys with glandular hypospadias, boys with coronal or penile hypospadias, and healthy boys

 


View larger version (25K):
[in this window]
[in a new window]
 
FIG. 2. Birth weight, birth length, head circumference, and weight for gestational age in boys with hypospadias divided by subtype. Boxes show median and quartiles; error bars show largest value not being an outlier. {circ}, Outlier; *, extreme.

 
At later examinations, we found that boys with coronal or penile hypospadias, as a group, had lower mean weight, compared with healthy boys. At 3 months, weight [mean (SD)] was 5.897 kg (0.995) vs. 6.521 kg (0.735), P = 0.012, height was 60.8 (3.1 cm) vs. 62.3 (2.1 cm), P = 0.048; also, head circumference tended to be smaller, although not significantly [40.5 cm (1.3) vs. 41.3 cm (1.3), P = 0.087]. At 18 months, weight was significantly smaller 10.879 kg (1.256) vs. 11.756 kg (1.251), P = 0.037, whereas height and head circumference did not differ significantly between the groups. At 36 months of age, weight was still smaller in boys with hypospadias, compared with healthy boys, 13.53 (1.58 kg) vs. 15.03 (1.60 kg), P = 0.014; height (SD) was 95.2 (3.5 cm) vs. 97.4 (3.6 cm), P = 0.090, whereas we found no significant differences in head circumference between the groups.

Reproductive hormones

At 3 months of age, we found significantly higher levels of FSH and higher FSH to inhibin B ratios among boys with hypospadias, compared with healthy boys. No other reproductive hormone differed significantly between healthy boys and boys with hypospadias (Table 3Go). We also found elevated FSH levels [median (95% prediction interval)] in the group of boys with glandular hypospadias alone, compared with healthy boys [1.43 IU/liter (0.62–3.99) vs. 1.15 IU/liter (0.41–2.85), P = 0.033]. FSH to inhibin B ratio tended to be elevated in boys with glandular hypospadias, compared with healthy boys [0.34 (0.17–1.16) vs. 0.29 (0.08–1.02), P = 0.095].


View this table:
[in this window]
[in a new window]
 
TABLE 3. Reproductive hormones at 3 months of age in boys with any type of hypospadias irrespective of age at diagnosis, compared with healthy boys [median (95% prediction interval)]

 
Analyses of reproductive hormones were performed irrespective of age at blood sampling to include as many boys as possible. However, when including only boys with more precise timing of blood sampling, i.e. at an age of 3 months ± 14 d, boys with hypospadias still had higher levels of FSH, compared with healthy boys [1.43 IU/liter (0.62–2.98) vs. 1.15 IU/liter (0.40–3.03), P = 0.040]. For the FSH to inhibin B ratio, boys with hypospadias still had a higher ratio, compared with healthy boys, albeit the difference was not statistically significant [0.33 (0.17–1.16) vs. 0.30 (0.08–1.08), P = 0.166].


    Discussion
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
In this prospective cohort study of Danish boys, we found a surprisingly high prevalence of hypospadias. Neonatally, we detected hypospadias in 1% of the boys. In an additional 3.3% of the 3-yr-old boys, milder cases of hypospadias were noticed when the prepuce could be retracted during a 3-yr follow-up period.

We do not exclude that some of the mild cases of hypospadias diagnosed during childhood could represent normal variants of penile morphology. However, these boys showed a trend toward impaired intrauterine growth, and basal FSH levels at 3 months of age were significantly higher than in healthy boys. The latter may imply an impaired testicular function necessitating an increased gonadotropic drive. Thus, the present findings corroborate the hypothesis that these cases are true, but mild, disorders of male genital development. Because all boys with late-diagnosed hypospadias had normal-looking prepuce, these cases may easily be overlooked unless genital examination includes a gentle attempt to retract the foreskin and inspect the urethral meatus if visible, also after the neonatal period.

Even disregarding these late-diagnosed hypospadias the Danish prevalence is very high, compared with previous data (1, 2, 3), although a birth rate of hypospadias of 0.73% was reported from The Netherlands in a recent cross-sectional study of boys examined before the age of 6 months (14). A Finnish cohort study closely coordinated with our study revealed a significantly lower rate of hypospadias of 0.27% (P = 0.012) (15). Furthermore, the Danish cases detected at birth were in general more severe than those in Finland in which only glandular and coronal cases were found. Thus, the present study confirmed an interesting difference between these two Nordic countries with regard to male reproductive health symptoms and lends support to the assumption that Danish more often than Finnish males suffer from testicular dysgenesis syndrome, which besides hypospadias entails testicular cancer, cryptorchidism, and spermatogenetic failure. The etiology of this syndrome is not yet clarified but may include developmental exposure to endocrine disrupting chemicals and/or lifestyle factors in combination with genetic susceptibility (7).

Our findings may represent an increase in the incidence of hypospadias in Denmark, although results from previous studies are not directly comparable. Sorensen (16) made an extensive retrospective examination of case notes, 1910–1945. Among boys alive at discharge (10 d old), he found a prevalence of hypospadias of 0.33% (90 of 27,613). Although the exact prevalence of subtypes was not established, the author estimated that three quarters were distal (16).

The prevalence of hypospadias in Denmark (Odense County) in 1997–2001 was estimated to be 12.85 per 10,000 total births according to EUROCAT (www.eurocat.ulster.ac.uk/; a joint European surveillance study). However, glandular hypospadias were not included in this register, thus underestimating the prevalence. Furthermore, several studies have suggested a substantial underascertainment of hypospadias in registers (1, 2, 6, 14), rendering register-based studies unsuitable for evaluation of geographic differences and temporal trends.

We found lower mean WGA and placental weights in boys with hypospadias irrespective of the subtype or age at diagnosis compared with healthy boys. Boys with coronal or penile hypospadias had lower mean birth weight, shorter mean birth length, smaller mean head circumference, and lower mean WGA, compared with healthy boys. Two of the boys with penile hypospadias had additionally congenital heart malformations, which could possibly affect the anthropometrical measurements. Yet the trend toward lower WGA also was found for boys with glandular and coronal hypospadias. These findings are in line with previous studies reporting that being small for gestational age rather than absolute birth weight is the dominating risk factor for hypospadias (17, 18, 19).

Previous epidemiological studies have found a close relationship between low birth weight and hypospadias (5, 17, 20, 21, 22). In monozygotic twins discordant for hypospadias, the twin with the lower birth weight was the one with hypospadias (23), and boys with hypospadias have been shown to have lower birth weights than their healthy brothers (18).

Birth weight exhibits well-known gender-specific differences, assumed to be associated with differences in fetal androgen levels (24, 25). We have previously described anthropometrical measurements in girls from the same cohort (26). Interestingly, birth weight and weight for gestational age in boys with coronal or penile hypospadias was actually smaller than those in girls. At 18 and 36 months of life, this group of boys still tended to be smaller than the average. The reasons for the association of hypospadias and other genital abnormalities with intrauterine growth retardation are currently not known, but defects of placental function and endocrine dysregulation have been hypothesized to be involved in these disorders.

Previous reports on reproductive hormones in boys with hypospadias have shown conflicting results, most probably due to differences in severity of hypospadias, age of the included cases, and the applied hormone assays (27, 28). No studies have thus far evaluated basal hormone levels during the early postnatal surge of reproductive hormones. Although there was no significant difference in serum testosterone and LH levels between the groups, the higher FSH values represent an increased gonadotropin drive of testicular function indicating a primary testicular dysfunction. Prenatal growth restraint has been shown to lead to elevated serum FSH concentrations in infant boys (29). However, only one boy with hypospadias was born SGA in our material. The group of boys with hypospadias in this study may be too small to detect differences in serum LH and testosterone because these reproductive hormones have only a brief postnatal peak (30).

The etiology of hypospadias remains obscure in most cases (31). There is a clear genetic component in the etiology illustrated by familial cases, although only a small percentage has been linked to single gene mutations (32). We found no androgen receptor mutations in the boys with penile hypospadias, and the number of CAG repeats were within the limits of the normal range in the Danish population (13). We hypothesize that some cases may be due to intrauterine exposure to environmental factors and that this could at least partly explain the difference in the prevalence between Denmark and Finland. Hypospadias in male rodents have been found after maternal treatment with potent estrogens (e.g. diethylstilbestrol), 5{alpha}-reductase inhibitors (e.g. finasteride), androgen receptor antagonists (e.g. vinclozolin; 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene; and prochloraz), and cytochrome P450 enzyme inhibitors (e.g. some fungicides) (33). Dietary exposure of pregnant rats to high levels of dibutyl phthalate also caused testicular dysgenesis, including hypospadias in the offspring (34).

In conclusion, in this large prospective cohort study we found a surprisingly high total rate of hypospadias of 4.6% in Denmark. Seventy-two percent of the cases were apparent in childhood only after the prepuce could be retracted. Hypospadias were associated with elevated serum FSH levels at 3 months. We also confirmed an association between fetal growth impairment and hypospadias; however, it is yet unknown whether this indicates a causal relationship or a shared pathogenic factor.


    Footnotes
 
This work was supported by The University of Copenhagen, The Danish Medical Research Council (Grants 9700833 and 9700909), Svend Andersens Fond, and the European Commission (contracts BMH4-CT96-0314, QLK4-CT1999-01422, and QLK4-2001-00269).

First Published Online May 3, 2005

Abbreviations: CI, Confidence interval; CV, coefficient of variation; SGA, small for gestational age; TDS, testicular dysgenesis syndrome; WGA, weight for gestational age.

Received February 14, 2005.

Accepted April 22, 2005.


    References
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 

  1. Kallen B, Bertollini R, Castilla E, Czeizel A, Knudsen LB, Martinez-Frias ML, Mastroiacovo P, Mutchinick O 1986 A joint international study on the epidemiology of hypospadias. Acta Paediatr Scand Suppl 324:5–52
  2. Toppari J, Kaleva M, Virtanen HE 2001 Trends in the incidence of cryptorchidism and hypospadias, and methodological limitations of registry-based data. Hum Reprod Update 7:282–286[Abstract/Free Full Text]
  3. Paulozzi LJ, Erickson JD, Jackson RJ 1997 Hypospadias trends in two U.S. surveillance systems. Pediatrics 100:831–834[Abstract/Free Full Text]
  4. Paulozzi LJ 1999 International trends in rates of hypospadias and cryptorchidism. Environ Health Perspect 107:297–302[Medline]
  5. Weidner IS, Moller H, Jensen TK, Skakkebaek NE 1999 Risk factors for cryptorchidism and hypospadias. J Urol 161:1606–1609[CrossRef][Medline]
  6. Dolk H, Vrijheid M, Scott JE, Addor MC, Botting B, de Vigan C, de Walle H, Garne E, Loane M, Pierini A, Garcia-Minaur S, Physick N, Tenconi R, Wiesel A, Calzolari E, Stone D 2004 Toward the effective surveillance of hypospadias. Environ Health Perspect 112:398–402[Medline]
  7. Skakkebaek NE, Rajpert-De Meyts E, Main KM 2001 Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 16:972–978[Abstract/Free Full Text]
  8. Boisen KA, Kaleva M, Main KM, Virtanen HE, Haavisto AM, Schmidt IM, Chellakooty M, Damgaard IN, Mau C, Reunanen M, Skakkebaek NE, Toppari J 2004 Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet 363:1264–1269[CrossRef][Medline]
  9. Larsen T 2001 Intrauterine growth restriction. Identification, correlation and causation evaluated by use of ultrasound. Dan Med Bull 48:257–274
  10. Batch JA, Williams DM, Davies HR, Brown BD, Evans BA, Hughes IA, Patterson MN 1992 Androgen receptor gene mutations identified by SSCP in fourteen subjects with androgen insensitivity syndrome. Hum Mol Genet 1:497–503[Abstract/Free Full Text]
  11. Giwercman A, Kledal T, Schwartz M, Giwercman YL, Leffers H, Zazzi H, Wedell A, Skakkebaek NE 2000 Preserved male fertility despite decreased androgen sensitivity caused by a mutation in the ligand-binding domain of the androgen receptor gene. J Clin Endocrinol Metab 85:2253–2259[Abstract/Free Full Text]
  12. Ihake R, Gentleman R 1996 R: a language for data analysis and graphics. J Comput Graph Stat 5:299–314[CrossRef]
  13. Rajpert-De Meyts E, Leffers H, Petersen HJ, Andersen AG, Carlsen E, Jorgensen N, Skakkebaek NE 2002 CAG repeat length in androgen-receptor gene and reproductive variables in fertile and infertile men. Lancet 359:44–46[CrossRef][Medline]
  14. Pierik FH, Burdorf A, Nijman JM, de Muinck Keizer-Schrama SM, Juttmann RE, Weber RF 2002 A high hypospadias rate in The Netherlands. Hum Reprod 17:1112–1115[Abstract/Free Full Text]
  15. Virtanen HE, Kaleva M, Haavisto AM, Schmidt IM, Chellakooty M, Main KM, Skakkebaek NE, Toppari J 2001 The birth rate of hypospadias in the Turku area in Finland. APMIS 109:96–100[CrossRef][Medline]
  16. Sorensen HR 1953 Hypospadias. With special reference to aetiology. Copenhagen: Munksgaard
  17. Hussain N, Chaghtai A, Herndon CD, Herson VC, Rosenkrantz TS, McKenna PH 2002 Hypospadias and early gestation growth restriction in infants. Pediatrics 109:473–478[Abstract/Free Full Text]
  18. Fredell L, Kockum I, Hansson E, Holmner S, Lundquist L, Lackgren G, Pedersen J, Stenberg A, Westbacke G, Nordenskjold A 2002 Heredity of hypospadias and the significance of low birth weight. J Urol 167:1423–1427[CrossRef][Medline]
  19. Calzolari E, Contiero MR, Roncarati E, Mattiuz PL, Volpato S 1986 Aetiological factors in hypospadias. J Med Genet 23:333–337[Abstract/Free Full Text]
  20. Akre O, Lipworth L, Cnattingius S, Sparén P, Ekbom A 1999 Risk factor patterns for cryptorchidism and hypospadias. Epidemiology 10:364–369[CrossRef][Medline]
  21. Avellán L 1977 On aetiological factors in hypospadias. Scand J Plast Reconstr Surg 11:115–123[Medline]
  22. Hughes IA, Northstone K, Golding J, ALSPAC Study Team 2002 Reduced birth weight in boys with hypospadias: an index of androgen dysfunction? Arch Dis Child Fetal Neonatal Ed 87:F150–F151
  23. Fredell L, Lichtenstein P, Pedersen NL, Svensson J 1998 Hypospadias is related to birth weight in discordant monozygotic twins. J Urol 160:2197–2199[CrossRef][Medline]
  24. de Zegher F, Francois I, Boehmer AL, Saggese G, Muller J, Hiort O, Sultan C, Clayton P, Brauner R, Cacciari E, Ibanez L, Van Vliet G, Tiulpakov A, Saka N, Ritzen M, Sippell WG 1998 Androgens and fetal growth. Horm Res 50:243–244[CrossRef][Medline]
  25. Francois I, Van Helvoirt M, De Zegher F 1999 Male pseudohermaphroditism related to complications at conception, in early pregnancy or in prenatal growth. Horm Res 51:91–95[CrossRef][Medline]
  26. Chellakooty M, Schmidt IM, Haavisto AM, Boisen KA, Damgaard IN, Mau C, Petersen JH, Juul A, Skakkebaek NE, Main KM 2003 Inhibin A, inhibin B, follicle-stimulating hormone, luteinizing hormone, estradiol, and sex hormone-binding globulin levels in 473 healthy infant girls. J Clin Endocrinol Metab 88:3515–3520[Abstract/Free Full Text]
  27. Feyaerts A, Forest MG, Morel Y, Mure PY, Morel-Journel N, Mallet D, Nicolino M, Chatelain P, David M, Mouriquand P 2002 Endocrine screening in 32 consecutive patients with hypospadias. J Urol 168:720–725[CrossRef][Medline]
  28. Gearhart JP, Donohoue PA, Brown TR, Walsh PC, Berkovitz GD 1990 Endocrine evaluation of adults with mild hypospadias. J Urol 144:274–277[Medline]
  29. Ibanez L, Valls C, Cols M, Ferrer A, Marcos MV, De Zegher F 2002 Hypersecretion of FSH in infant boys and girls born small for gestational age. J Clin Endocrinol Metab 87:1986–1988[Abstract/Free Full Text]
  30. Andersson AM, Toppari J, Haavisto AM, Petersen JH, Simell T, Simell O, Skakkebaek NE 1998 Longitudinal reproductive hormone profiles in infants: peak of inhibin B levels in infant boys exceeds levels in adult men. J Clin Endocrinol Metab 83:675–681[Abstract/Free Full Text]
  31. Albers N, Ulrichs C, Gluer S, Sinnecker GHG, Mildenberger H, Brodehl J 1997 Etiologic classification of severe hypospadias: implications for prognosis and management. J Pediatr 131:386–392[Medline]
  32. Baskin LS, Himes K, Colborn T 2001 Hypospadias and endocrine disruption: is there a connection? Environ Health Perspect 109:1175–1183[Medline]
  33. Gray Jr LE, Ostby J, Furr J, Wolf C, Lambright C, Wilson V, Noriega N 2004 Toxicant-induced hypospadias in the male rat. Adv Exp Med Biol 545:217–241[Medline]
  34. Fisher JS, Macpherson S, Marchetti N, Sharpe RM 2003 Human "testicular dysgenesis syndrome": a possible model using in utero exposure of the rat to dibutyl phthalate. Hum Reprod 18:1383–1394[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Hum ReprodHome page
O. Akre and L. Richiardi
Does a testicular dysgenesis syndrome exist?
Hum. Reprod., May 14, 2009; (2009) dep174v1.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
N. Kalfa, B. Liu, K. Ophir, F. Audran, M.-H. Wang, C. Mei, C. Sultan, and L. S Baskin
Mutations of CXorf6 are associated with a range of severities of hypospadias
Eur. J. Endocrinol., October 1, 2008; 159(4): 453 - 458.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. Mau Kai, A. Juul, K. McElreavey, A.M. Ottesen, I.D. Garn, K.M. Main, A. Loft, N. Jorgensen, N.E. Skakkebaek, A. N. Andersen, et al.
Sons conceived by assisted reproduction techniques inherit deletions in the azoospermia factor (AZF) region of the Y chromosome and the DAZ gene copy number
Hum. Reprod., July 1, 2008; 23(7): 1669 - 1678.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
H. Shen, K. M. Main, A.-M. Andersson, I. N. Damgaard, H. E. Virtanen, N. E. Skakkebaek, J. Toppari, and K.-W. Schramm
Concentrations of persistent organochlorine compounds in human milk and placenta are higher in Denmark than in Finland
Hum. Reprod., January 1, 2008; 23(1): 201 - 210.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Bay, H. E. Virtanen, S. Hartung, R. Ivell, K. M. Main, N. E. Skakkebaek, A.-M. Andersson, The Nordic Cryptorchidism Study Group, and J. Toppari
Insulin-Like Factor 3 Levels in Cord Blood and Serum from Children: Effects of Age, Postnatal Hypothalamic-Pituitary-Gonadal Axis Activation, and Cryptorchidism
J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 4020 - 4027.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. Asklund, N. Jorgensen, N.E. Skakkebaek, and T.K. Jensen
Increased frequency of reproductive health problems among fathers of boys with hypospadias
Hum. Reprod., October 1, 2007; 22(10): 2639 - 2646.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
P. Saenger, P. Czernichow, I. Hughes, and E. O. Reiter
Small for Gestational Age: Short Stature and Beyond
Endocr. Rev., April 1, 2007; 28(2): 219 - 251.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
T. K. Jensen, N. Jorgensen, C. Asklund, E. Carlsen, M. Holm, and N. E. Skakkebaek
Fertility Treatment and Reproductive Health of Male Offspring: A Study of 1,925 Young Men from the General Population
Am. J. Epidemiol., March 1, 2007; 165(5): 583 - 590.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Mau Kai, K. M. Main, A. Nyboe Andersen, A. Loft, M. Chellakooty, N. E. Skakkebaek, and A. Juul
Serum Insulin-Like Growth Factor-I (IGF-I) and Growth in Children Born after Assisted Reproduction
J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4352 - 4360.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
K. M Main, J. Toppari, and N. E Skakkebaek
Gonadal development and reproductive hormones in infant boys
Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S51 - S57.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
C L Acerini and I A Hughes
Endocrine disrupting chemicals: a new and emerging public health problem?
Arch. Dis. Child., August 1, 2006; 91(8): 633 - 641.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. M. Sharpe
Perinatal Determinants of Adult Testis Size and Function.
J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2503 - 2505.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. M. Main, J. Toppari, A.-M. Suomi, M. Kaleva, M. Chellakooty, I. M. Schmidt, H. E. Virtanen, K. A. Boisen, C. M. Kai, I. N. Damgaard, et al.
Larger Testes and Higher Inhibin B Levels in Finnish than in Danish Newborn Boys
J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2732 - 2737.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
L. Aksglaede, A. Juul, H. Leffers, N. E. Skakkebaek, and A.-M. Andersson
The sensitivity of the child to sex steroids: possible impact of exogenous estrogens
Hum. Reprod. Update, July 1, 2006; 12(4): 341 - 349.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
E. Rajpert-De Meyts
Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects
Hum. Reprod. Update, May 1, 2006; 12(3): 303 - 323.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A.-M. Suomi, K. M. Main, M. Kaleva, I. M. Schmidt, M. Chellakooty, H. E. Virtanen, K. A. Boisen, I. N. Damgaard, C. M. Kai, N. E. Skakkebaek, et al.
Hormonal Changes in 3-Month-Old Cryptorchid Boys
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 953 - 958.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. A. Rey, E. Codner, G. Iniguez, P. Bedecarras, R. Trigo, C. Okuma, S. Gottlieb, I. Bergada, S. M. Campo, and F. G. Cassorla
Low Risk of Impaired Testicular Sertoli and Leydig Cell Functions in Boys with Isolated Hypospadias
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6035 - 6040.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boisen, K. A.
Right arrow Articles by Main, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boisen, K. A.
Right arrow Articles by Main, K. M.
Related Collections
Right arrow Pediatric Endocrinology
Right arrow Male Endocrinology


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals